Immix Biopharma, Inc. · NASDAQ:IMMX
Eventide Asset Management, LLC reported a 5.60% stake in Immix Biopharma, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Eventide Asset Management, LLC reported a 5.60% stake in Immix Biopharma, Inc., 3,891,019 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 3,891,019
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eventide Asset Management, LLC | 5.60% | 3,891,019 |
| Finny Kuruvilla, M.D. Ph. D. | 5.60% | 3,891,019 |
| Robin C. John | 5.60% | 3,891,019 |
Source
Related
- Immix Biopharma, Inc.
- Eventide Asset Management, LLC
- Immix Biopharma, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jun 5, 2026
- Form 4 · Ng Carey · May 29, 2026
- Form 4 · Adams Helen C. · May 29, 2026
- Form 4 · Marquet Magda · May 29, 2026